Patent directory · USPTO A61K / A61P
Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”
783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10485879
Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues
granted -
US 10449231
Compositions and methods for dengue virus chimeric constructs in vaccines
granted -
US 10421952
Mutant organophosphorus acid anhydrolase enzymes having increased catalytic efficiency on V-agents
granted -
US 10400031
Identification of antibodies specific for lyssaviruses and methods of their use
granted -
US 10383945
Methods for DNA-dependent targeting of a cell permeant antibody
granted -
US 10363289
Mutant OPAA enzyme with increased catalytic efficiency on GP
granted -
US 10357554
AMA-1 epitopes, antibodies, compositions, and methods of making and using the same
granted -
US 10351844
Methods and compositions for treating leber congenital amaurosis
granted -
US 10350306
Methods and compositions for treating genetically linked diseases of the eye
granted -
US 10342791
Regimens of tafenoquine for prevention of malaria in malaria-naive subjects
granted -
US 10335365
Bladder cancer specific ligand peptides
granted -
US 10335465
Mutant OPAA enzyme with increased catalytic efficiency on organophosphorus compound GP
granted -
US 10322125
TGF-beta enhancing compositions for cartilage repair and methods related thereto
granted -
US 10314908
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 10307477
Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
granted -
US 10300095
AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
granted -
US 10286064
Cationic lipid vaccine compositions and methods of use
granted -
US 10260054
Engineered organophosphorus acid anhydrolases and methods of use thereof
granted -
US 10258686
Materials and methods for respiratory disease control in canines
granted -
US 10227395
Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin
granted -
US 10213445
Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer
granted -
US 10196612
Method of characterizing and manipulating adipose stem cell depots to a metabolically healthy state
granted -
US 10196603
Aligned and electrospun piezoelectric polymer fiber assembly and scaffold
granted -
US 10188714
Yeast-MUC1 immunotherapeutic compositions and uses thereof
granted